Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 360-degree synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of plantar fasciitis
3.2.1.2 Growing demand for non-invasive treatment procedures
3.2.1.3 Technological advancements in treatment modalities
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost associated with certain treatment
3.2.2.2 Potential adverse reactions and side effects
3.3 Growth potential analysis
3.4 Porter's analysis
3.5 PESTEL analysis
3.6 Regulatory landscape
3.7 Technological landscape
3.8 Reimbursement scenario
3.9 Future market trends
3.10 Gap analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Treatment Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Therapy
5.2.1 Orthotic devices
5.2.2 Shockwave therapy
5.2.2.1 Extracorporeal shockwave therapy (ESWT)
5.2.2.2 Intracorporeal pneumatic shock therapy (IPST)
5.2.3 Ultrasound therapy
5.2.4 Other therapies
5.3 Medication therapy
5.3.1 Nonsteroidal anti-inflammatory drugs (NSAIDs)
5.3.2 Corticosteroid injections
5.3.3 Topical pain relievers
5.4 Surgery
5.4.1 Plantar fascia release
5.4.2 Gastrocnemius recession
5.4.3 Tendon transfer
Chapter 6 Market Estimates and Forecast, By Indication, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Mild
6.3 Moderate
6.4 Severe
Chapter 7 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Orthopedic clinics
7.4 Physiotherapy centers
7.5 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1. 3 M
9.2 A. Algeo Ltd.
9.3 Bauerfeind USA Inc.
9.4 Hanger, Inc.
9.5 OrthoBethesda
9.6 OrthoMed, Inc.
9.7 Ottobock
9.8 Pfizer, Inc.
9.9 Revance Therapeutics, Inc.
9.10 Sanofi
